Comparative effectiveness of antihypertensive medication for primary prevention of cardiovascular disease: systematic review and multiple treatments meta-analysis (Q30514101)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Comparative effectiveness of antihypertensive medication for primary prevention of cardiovascular disease: systematic review and multiple treatments meta-analysis	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

11 August 2017

1 reference

11 December 2020

systematic review

1 reference

1 reference

comparative study

1 reference

Comparative effectiveness of antihypertensive medication for primary prevention of cardiovascular disease: systematic review and multiple treatments meta-analysis (English)

1 reference

Europe PubMed Central

11 August 2017

myocardial infarction

1 reference

12 November 2020

1 reference

12 November 2020

cardiovascular disease

1 reference

based on heuristic

inferred from title

primary prevention

1 reference

12 November 2020

antihypertensive drug

1 reference

4 December 2020

chemoprophylaxis

1 reference

11 December 2020

systematic review

1 reference

based on heuristic

inferred from title

object named as

Signe Flottorp

10

0 references

Ole Frithjof Norheim

object named as

Ole F Norheim

6

0 references

4

object named as

Steinar Madsen

1 reference

Europe PubMed Central

11 August 2017

Inger Njølstad

5

object named as

Inger Njølstad

1 reference

Europe PubMed Central

11 August 2017

1

object named as

Atle Fretheim

1 reference

Europe PubMed Central

11 August 2017

3

object named as

Odd Brørs

1 reference

Europe PubMed Central

11 August 2017

7

object named as

Arne Svilaas

1 reference

Europe PubMed Central

11 August 2017

author name string

Jan Odgaard-Jensen

2

1 reference

Europe PubMed Central

11 August 2017

Ivar S Kristiansen

8

1 reference

Europe PubMed Central

11 August 2017

Hanne Thürmer

9

1 reference

Europe PubMed Central

11 August 2017

language of work or name

0 references

publication date

5 April 2012

10 references

Europe PubMed Central

11 August 2017

19 March 2019

22 March 2019

25 April 2019

17 June 2019

25 June 2019

22 July 2019

12 November 2020

4 December 2020

11 December 2020

10 references

Europe PubMed Central

11 August 2017

19 March 2019

22 March 2019

25 April 2019

17 June 2019

25 June 2019

22 July 2019

12 November 2020

4 December 2020

11 December 2020

10

1 reference

Europe PubMed Central

11 August 2017

33

1 reference

Europe PubMed Central

11 August 2017

copyright license

Creative Commons Attribution 2.0 Generic

9 references

Europe PubMed Central

19 March 2019

Europe PubMed Central

22 March 2019

Europe PubMed Central

25 April 2019

Europe PubMed Central

17 June 2019

Europe PubMed Central

25 June 2019

Europe PubMed Central

22 July 2019

Europe PubMed Central

12 November 2020

Europe PubMed Central

4 December 2020

Europe PubMed Central

11 December 2020

copyright status

0 references

on focus list of Wikimedia project

0 references

https://scigraph.springernature.com/pub.10.1186/1741-7015-10-33

0 references

GRADE guidelines: 3. Rating the quality of evidence

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3354999

20 June 2018

Antihypertensive treatment and development of heart failure in hypertension: a Bayesian network meta-analysis of studies in patients with hypertension and high cardiovascular risk

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3354999

20 June 2018

Checking consistency in mixed treatment comparison meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3354999

20 June 2018

First-line drugs for hypertension

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3354999

20 June 2018

Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3354999

20 June 2018

Treatment of hypertension in patients 80 years of age or older

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3354999

20 June 2018

Evaluation of networks of randomized trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3354999

20 June 2018

Valsartan in a Japanese population with hypertension and other cardiovascular disease (Jikei Heart Study): a randomised, open-label, blinded endpoint morbidity-mortality study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3354999

20 June 2018

Beta-blockers for hypertension

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3354999

20 June 2018

Incident diabetes in clinical trials of antihypertensive drugs: a network meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3354999

20 June 2018

Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (A

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3354999

20 June 2018

Calcium channel blocker class heterogeneity: select aspects of pharmacokinetics and pharmacodynamics

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3354999

20 June 2018

Atenolol in hypertension: is it a wise choice?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3354999

20 June 2018

Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3354999

20 June 2018

The world health report 2002 - reducing risks, promoting healthy life

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3354999

20 June 2018

Should evidence-based proof of drug efficacy be extrapolated to a "class of agents"?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3354999

20 June 2018

Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3354999

20 June 2018

Treatment of isolated systolic hypertension: the SHELL study results

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3354999

20 June 2018

Pharmaceutical industry sponsorship and research outcome and quality: systematic review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3354999

20 June 2018

Health outcomes associated with various antihypertensive therapies used as first-line agents: a network meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3354999

20 June 2018

A comparison of outcomes with angiotensin-converting--enzyme inhibitors and diuretics for hypertension in the elderly.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3354999

20 June 2018

Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3354999

20 June 2018

A new system for grading recommendations in evidence based guidelines

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3354999

20 June 2018

Systematic review of antihypertensive therapies: does the evidence assist in choosing a first-line drug?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3354999

20 June 2018

Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3354999

20 June 2018

Bias in meta-analysis detected by a simple, graphical test

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3354999

20 June 2018

Randomised trial of treatment of hypertension in elderly patients in primary care

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3354999

20 June 2018

Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3354999

20 June 2018

Blood pressure, stroke, and coronary heart disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3354999

20 June 2018

Outcomes with nifedipine GITS or Co-amilozide in hypertensive diabetics and nondiabetics in Intervention as a Goal in Hypertension (INSIGHT).

1 reference

https://api.crossref.org/works/10.1186%2F1741-7015-10-33

21 January 2018

Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

1 reference

https://api.crossref.org/works/10.1186%2F1741-7015-10-33

21 January 2018

Principal Results of the Controlled Onset Verapamil Investigation of Cardiovascular End Points (CONVINCE) Trial

1 reference

https://api.crossref.org/works/10.1186%2F1741-7015-10-33

21 January 2018

Results of the pilot study for the Hypertension in the Very Elderly Trial

1 reference

https://api.crossref.org/works/10.1186%2F1741-7015-10-33

21 January 2018

Effects of candesartan on cardiovascular outcomes in Japanese hypertensive patients

1 reference

https://api.crossref.org/works/10.1186%2F1741-7015-10-33

21 January 2018

Effects of candesartan compared with amlodipine in hypertensive patients with high cardiovascular risks: candesartan antihypertensive survival evaluation in Japan trial.

1 reference

https://api.crossref.org/works/10.1186%2F1741-7015-10-33

21 January 2018

Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators.

1 reference

https://api.crossref.org/works/10.1186%2F1741-7015-10-33

21 January 2018

Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients

1 reference

https://api.crossref.org/works/10.1186%2F1741-7015-10-33

21 January 2018

Effects of valsartan on morbidity and mortality in uncontrolled hypertensive patients with high cardiovascular risks: KYOTO HEART Study

1 reference

https://api.crossref.org/works/10.1186%2F1741-7015-10-33

21 January 2018

The Study on Cognition and Prognosis in the Elderly (SCOPE): principal results of a randomized double-blind intervention trial

1 reference

https://api.crossref.org/works/10.1186%2F1741-7015-10-33

21 January 2018

Clinical efficacies of antihypertensive drugs.

1 reference

https://api.crossref.org/works/10.1186%2F1741-7015-10-33

21 January 2018

Management of hypertension: summary of NICE guidance

1 reference

https://api.crossref.org/works/10.1186%2F1741-7015-10-33

21 January 2018

Effects of treatment on morbidity in hypertension. II. Results in patients with diastolic blood pressure averaging 90 through 114 mm Hg

1 reference

https://pubmed.ncbi.nlm.nih.gov/22480336

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of mild hypertension: a five year controlled drug trial. The Oslo study

1 reference

https://pubmed.ncbi.nlm.nih.gov/22480336

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mortality and morbidity results from the European Working Party on High Blood Pressure in the Elderly trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/22480336

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized double-blind comparison of a calcium antagonist and a diuretic in elderly hypertensives. National Intervention Cooperative Study in Elderly Hypertensives Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/22480336

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomised trial of old and new antihypertensive drugs in elderly patients: cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension-2 study

1 reference

https://pubmed.ncbi.nlm.nih.gov/22480336

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). ALLHAT Collaborative Research Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/22480336

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Practitioner's Trial on the Efficacy of Antihypertensive Treatment in the Elderly Hypertension (The PATE-Hypertension Study) in Japan

1 reference

https://pubmed.ncbi.nlm.nih.gov/22480336

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomised trial of effects of calcium antagonists compared with diuretics and beta-blockers on cardiovascular morbidity and mortality in hypertension: the Nordic Diltiazem (NORDIL) study

1 reference

https://pubmed.ncbi.nlm.nih.gov/22480336

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cardiovascular risk and risk factors in a randomized trial of treatment based on the beta-blocker oxprenolol: the International Prospective Primary Prevention Study in Hypertension (IPPPSH). The IPPPSH Collaborative Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/22480336

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Beta-blockers versus diuretics in hypertensive men: main results from the HAPPHY trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/22480336

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension)

1 reference

https://pubmed.ncbi.nlm.nih.gov/22480336

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Medical Research Council trial of treatment of hypertension in older adults: principal results. MRC Working Party

1 reference

https://pubmed.ncbi.nlm.nih.gov/22480336

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A 12-month comparison of ACE inhibitor and CA antagonist therapy in mild to moderate essential hypertension--The GLANT Study. Study Group on Long-term Antihypertensive Therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/22480336

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Prevention and treatment of stroke after hypertension for ten years in Hunan Province]

1 reference

https://pubmed.ncbi.nlm.nih.gov/22480336

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/1741-7015-10-33

1 reference

Europe PubMed Central

11 August 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

11 August 2017

1 reference

Europe PubMed Central

11 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q30514101&oldid=2117031799"